AGREEMENT

EX-10.1 2 exhibit101.htm 10.1 exhibit101.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing

Exhibit 10.1

AGREEMENT

     This Agreement (this “Agreement”) is made and entered into as of September 7, 2007, by and among Pershing Square, L.P., Pershing Square II, L.P. and Pershing Square International, Ltd. (collectively the “Pershing Square Funds”), and Ceridian Corporation, a Delaware corporation (“Ceridian”).

RECITALS

     A. Ceridian is scheduled to hold its annual meeting on September 12, 2007 (the “Annual Meeting”). The agenda for the Annual Meeting includes, among other things, a vote on the merger (the “Merger”) contemplated by the Agreement and Plan of Merger by and among Foundation Holdings, Inc., Foundation Merger Sub, Inc. and Ceridian, dated as of May 30, 2007 and amended on July 30, 2007 (as so amended, the “Merger Agreement”), and the election of the Ceridian board of directors (the “Ceridian Board”).

     B. The Pershing Square Funds own in the aggregate 21,432,734 shares of Ceridian common stock and have pending a proxy solicitation to elect their proposed slate to the Ceridian Board.

     C. The Parties hereto agree that it is in the best interests of all Ceridian stockholders to come to an amicable agreement with respect to the proxy contest.

     NOW THEREFORE, the parties hereby agree as follows:

     1. The Pershing Square Funds and Ceridian and agree to issue the joint press release in the form attached as Exhibit A.

     2. The Pershing Square Funds agree to terminate their proxy solicitation and withdraw their nominations with respect to the Annual Meeting and to vote all shares of Ceridian common stock beneficially owned by them in favor of the Merger Agreement and the reelection of the current Ceridian Board’s nominees (the “Incumbent Directors”).

     3. Ceridian agrees, and represents and warrants that the Ceridian Board has agreed, that immediately after the Annual Meeting the Ceridian Board will take all action necessary to increase the size of the Ceridian Board to eleven members and to fill the four vacancies created by that increase with the following people: John D. Barfitt, Paul C. Hilal, Robert J. Levenson and Gregory A. Pratt (collectively, “Designated Directors”).

     4. Ceridian agrees, and represents and warrants that the Ceridian Board has agreed, that between the time of the Annual Meeting and the earlier of the closing of the Merger and the election and qualification of directors following the Next Meeting referred to below, (a) the size of the Ceridian Board will not be increased beyond eleven members, (b) other than (i) the Designated Directors added pursuant to (3) above, (ii) replacements for Designated Directors selected by the Pershing Square Funds and (iii) replacements for Incumbent Directors selected by the remaining Incumbent Directors, no new Board members


will be added to the Ceridian Board, and (c) at least one Designated Director will be given the opportunity to join each committee of the Ceridian Board.

     5. Ceridian agrees, and represents and warrants that the Ceridian Board has agreed, that in the event the Merger Agreement is terminated, during the period between the time of termination of the Merger Agreement and the election and qualification of directors following the Next Meeting referred to below, Ceridian shall not, without the approval of a majority of the Ceridian Board that includes the approval of two of the Designated Directors (the “Special Approval”), take any action that would require the approval of the Ceridian Board or any committee thereof pursuant to the Delegation of Authority attached hereto as Exhibit B (the “Delegation of Authority”); provided that during such period if the amount of any items covered by Sections I, II, III an d XII under the heading “Expenditure & Commitment Approvals” in the Delegation of Authority exceeds $25 million in the aggregate in excess of amounts contemplated by Ceridian’s previously approved capital plan, such items shall require the Special Approval; and provided, further, that during such period any action prohibited by Sections 5.1(b)(i) (other than cash dividends), 5.1(b)(ii), 5.1(b)(vi) (other than for employee compensation in the ordinary course of business) or 5.1(b)(vii) of the Merger Agreement shall require the Special Approval. For purposes of the second proviso of the preceding sentence, (a) the Merger Agreement will be deemed to remain in effect even though in the circumstances contemplated by that proviso it shall have been terminated and (b) no effect will be given to any waivers, amendments or consents that Parent may have agreed to in the past or agree to in the future. Notwithstanding the foregoing, the nomination of a slate of directors for election at the Next Meeting shall require only a simple majority approval of the Ceridian Board and shall not require the Special Approval.

     6. Ceridian agrees, and represents and warrants that the Ceridian Board has agreed, that in the event the Merger Agreement is terminated, (a) Ceridian will hold the 2008 Annual Meeting of Stockholders or a special meeting of stockholders (either such meeting, the “Next Meeting”) as soon as possible and in any event within 90 calendar days after such termination to vote on the election of the entire board of directors of Ceridian and (b) the then current directors of Ceridian will take all actions necessary to facilitate such election.

     7. The parties to this Agreement agree that irreparable damage would occur if any provision of this Agreement were not strictly performed in accordance with its terms and that each party to this Agreement shall be entitled to an injunction to prevent breaches of this Agreement and to enforce specifically the performance of the provisions hereof in any federal court located in Delaware or in any Delaware state court, in addition to any other remedy to which any party may be entitled at law or in equity.

     8. The parties to this Agreement agree that any suit, action or proceeding to enforce any provision of, or based on any matter arising out of or in connection with, this Agreement may be brought only in a federal court located in Delaware or in any Delaware state court, and each party irrevocably consents to the jurisdiction of such courts (and of the appellate courts therefrom) in any such suit, action or proceeding and irrevocably waives any objection it may now or hereafter have to the laying of venue of any such suit, action or

-2-


proceeding in any such court or that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum.

     9. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware without giving effect to any conflict of law rules that would otherwise cause the application of the laws of any other state.

     IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written.

CERIDIAN CORPORATION 
 
 
By:  /s/ Kathryn V. Marinello                              
         Name:  Kathryn V. Marinello
         Title:  President and Chief Executive Officer
 
PERSHING SQUARE, L.P. 
By: Pershing Square GP, LLC, 
                   its General Partner 
 
 
By:  /s/ William A. Ackman                                 
         Name: William A. Ackman 
         Title: Managing Member 
 
PERSHING SQUARE II, L.P. 
By: Pershing Square GP, LLC, 
                   its General Partner 
 
 
By:  /s/ William A. Ackman                                  
         Name: William A. Ackman 
         Title: Managing Member 
 
PERSHING SQUARE INTERNATIONAL, LTD. 
By: Pershing Square Capital Management, L.P 
                   its Investment Manager 
By: PS Management GP, LLC 
                   its Investment Manager 
 
 
By:  /s/ William A. Ackman                                  
         Name: William A. Ackman 
         Title: Managing Member 

-3-